Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza and Simvastatin Extension in Hypertriglyceridemia
NCT00903409Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia, sponsored by GSK. Started Nov 2005; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT00903409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903409.